Director and Head of Investor Relations
Phone - Direct: +46 8 587 254 15
As pioneers of future technology, Elekta is setting a new standard of cancer care
once again with magnetic resonance radiation therapy (MR/RT).
MR/RT addresses an unmet need in cancer therapy, enabling clinicians to
confidently see and track difficult to visualize soft-tissue anatomies.
A member of the Elekta patents team will be in touch shortly.
For further information please contact: email@example.com